期刊文献+

完全型雄激素不敏感综合征合并无性细胞瘤1例

在线阅读 下载PDF
导出
摘要 患者30岁,女性,因发现盆腔包块伴下腹胀痛3个月,2020年5月入浙江大学医学院附属第二医院余杭分院就诊,合并盆腔内无性细胞瘤。患者自诉幼年时于当地医院诊断为始基子宫,月经从未来潮,有一弟弟及妹妹,其中妹妹性别正常,月经正常,家族中无类似病史。患者已婚7年,有性生活。入院3个月前出现下腹胀痛,下腹可触及包块。2020年3月本院B超显示:盆腔内不均质低回声团(12.1 cm×9.2 cm×8.0 cm),双肾扫描未见明显异常。患者因经济原因未立即住院治疗。入院前复查B超显示:右侧卵巢可及,大小约3.6 cm×1.8 cm,回声偏实,左侧卵巢因团块及气体干扰显示不清,盆腔内巨大低回声团块伴钙化(15.7 cm×12.4 cm×9.8 cm),内血流丰富,性质待定,子宫及宫颈均未见显示。
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2020年第20期1076-1078,共3页 Chinese Journal of Clinical Oncology
作者简介 通信作者:冯导,fengdao1966@163.com;周晓倩,专业方向为妇科肿瘤的诊断与治疗,E-mail:1261827453@qq.com。
  • 相关文献

参考文献3

二级参考文献38

  • 1Braicu El, Fotopoulou C, Van Gorp T, et al. Preoperative HEal ex- pression in plasma predicts surgical outcome in primary ovarian cancer patients:results fi'om the OVCAD study [J]. Gynecol On-col,2012,128:245-251.
  • 2Angioli R, Plotti F, Capriglione S, et al. Can the preoperative HE4 level predict optimal eytoreduction in patients with ad- vanced ovarian carcinoma? [J].Gyneco] Oncol,2013,128:579- 583.
  • 3Angioli R, Capriglione S, Aloisi A, et al. Can HE4 predict plati- num response during first-line chemotherapy in ovarian can- cer?[J].Tumour Biol,2014,35(7):7009-7015.
  • 4Xu L, Cai J, Yang Q, et al. Prognostic significance of several bio- markers in epithelial ovarian cancer: a meta-analysis of pub- lished studies [J ]. J Cancer Res Clin Oncol, 2013, 139(8): 1257- 1277.
  • 5Cai J, Xu L, Tang H, et al. The role of the PTEN/PI3K/Akt path- way on prognosis in epithelial ovarian cancer: a meta- analy- sis [J ]. Oncologist, 2014, 19(5):528-535.
  • 6Cao J, Cai J, Huang D, et al. miR-335 represents an indepen- dent prognostic marker in epithelial ovarian cancer [J]. Am J Clin Pathol, 2014,141(3):437-442.
  • 7Lee H, Park CS, Deftereos G, et al. MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features[J]. World J Surg Oncol,2012,10:174.
  • 8Nam EJ, Yoon H, Kim SW, et al. MicroRNA expression profiles in serous ovarian carcinoma [J]. Clin Cancer Res, 2008, 14: 2690-2695.
  • 9Davidson B, Trop CG, Reich R.The clinical and diagnostic role of microRNAs in ovarian carcinoma [J]. Gynecol Oncol, 2014, 133(3):640-646.
  • 10Lee CH, Subramanian S, Beck AH, et al. MicroRNA profiling of BRCA 1/2 mutation-carrying and non--mutation--cmYying high- grade serous earei as of ovary [J]. PLoS One, 2009,4(10): e7314.

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部